Literature DB >> 19028535

Acute neurohumoral modulation of diastolic function.

Ricardo Ladeiras-Lopes1, João Ferreira-Martins, Adelino F Leite-Moreira.   

Abstract

Diastole plays a central role in cardiovascular homeostasis. Its two main determinants, myocardial relaxation and passive properties of the ventricular wall, are nowadays regarded as physiological mechanisms susceptible of active modulation. Furthermore, diastolic dysfunction and heart failure with normal ejection fraction (previously called diastolic heart failure) are two subjects of major clinical relevance and an intense area of research. The role of several neurohumoral mediators like angiotensin-II and endothelin-1 on the modulation of diastolic function was systematically described as having only chronic deleterious effects such as cardiac hypertrophy and fibrosis. However, over the last years a growing body of evidence described a new role for several peptides on the acute modulation of diastolic function. In the acute setting, some of these mediators may have the potential to induce an adaptive cardiac response. In this review, we describe the role of angiotensin-II, endothelin-1, nitric oxide, urotensin-II and ghrelin on the acute modulation of diastolic function, emphasizing its pathophysiological relevance. Only a thorough understanding of diastolic physiology as well as its active modulation, both in the acute and chronic settings, will improve our knowledge on diastolic dysfunction and allow us to solve the enigmas of heart failure with normal ejection fraction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19028535     DOI: 10.1016/j.peptides.2008.10.018

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  6 in total

1.  Biomarker changes during acute heart failure treatment.

Authors:  Brent Boyer; Kimberly W Hart; Matthew I Sperling; Christopher J Lindsell; Sean P Collins
Journal:  Congest Heart Fail       Date:  2011-10-17

2.  Metformin in non-diabetic patients with metabolic syndrome and diastolic dysfunction: the MET-DIME randomized trial.

Authors:  Ricardo Ladeiras-Lopes; Francisco Sampaio; Sara Leite; Diogo Santos-Ferreira; Eduardo Vilela; Adelino Leite-Moreira; Nuno Bettencourt; Vasco Gama; Pedro Braga; Ricardo Fontes-Carvalho
Journal:  Endocrine       Date:  2021-04-08       Impact factor: 3.633

3.  Physiologic basis and pathophysiologic implications of the diastolic properties of the cardiac muscle.

Authors:  João Ferreira-Martins; Adelino F Leite-Moreira
Journal:  J Biomed Biotechnol       Date:  2010-06-02

4.  Endothelin-1 levels in chronic congestive heart failure.

Authors:  Minoru Ohmae
Journal:  Wien Klin Wochenschr       Date:  2011-11-28       Impact factor: 2.275

5.  Renin-Angiotensin Activation and Oxidative Stress in Early Heart Failure with Preserved Ejection Fraction.

Authors:  Smita I Negi; Euy-Myoung Jeong; Irfan Shukrullah; Emir Veleder; Dean P Jones; Tai-Hwang M Fan; Sudhahar Varadarajan; Sergei M Danilov; Tohru Fukai; Samuel C Dudley
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

Review 6.  Acute Myocardial Response to Stretch: What We (don't) Know.

Authors:  João S Neves; André M Leite-Moreira; Manuel Neiva-Sousa; João Almeida-Coelho; Ricardo Castro-Ferreira; Adelino F Leite-Moreira
Journal:  Front Physiol       Date:  2016-01-05       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.